SCHEMBL7961759

SCHEMBL7961759

Oc1c(Cl)cc(Nc2nc(Nc3cc(Cl)c(O)c(Cl)c3)nc(Nc3cc(Cl)c(O)c(Cl)c3)n2)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ RECQL P46063 1/20 0.44
▸ MAPT P10636 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ THRB P10828 1/20 0.41
▸ APP P05067 2/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ GSK3B P49841 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23643511 0.90 NFKB1 (0.52) TTRHSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL23643400 0.86 TTR (0.38) TTRHSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL655459 0.74 AURKA (0.61) GSK3BGSK3ASLKAURKA
SCHEMBL2087642 0.73 BACE1 (0.42) RECQLMAPTMEN1MAPK1KMT2A
SCHEMBL7960772 0.73 CYP3A4 (0.44) TTRHSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL17108185 0.71 TTR (0.46) TTRHSD17B10ALDH1A1CYP3A4TSHR
SCHEMBL8973726 0.71 NFKB1 (0.55) TSHRMAPTMEN1MAPK1KMT2A
SCHEMBL10869800 0.70 NPC1 (0.46) ALDH1A1MAPTMEN1MAPK1KMT2A
SCHEMBL23643419 0.70 NFKB1 (0.53) MAPTMEN1MAPK1KMT2AAPP
SCHEMBL10429500 0.70 NPY5R (0.50) MAPTMEN1KMT2AAPPGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6262053-B1 EFFECTIVE FOR TREATING TUMOR CELLS AND PARTICULARLY EFFECTIVE TO INDUCE APOPTOSIS IN LEUKEMIA AND BREAST TUMOR CELLS. PARKER HUGHES INSTITUTE 2001-07-17 — — US claimed
Send feedback